# Comparing 68Ga-FAPI PET-Guided Abdominal Radiotherapy Combined With Second-Line Standard Therapy and Cadonilimab Versus Second-Line Standard Therapy in Colorectal Cancer With Peritoneal Metastasis

> **NCT07079462** · PHASE2 · RECRUITING · sponsor: **Fudan University** · enrollment: 40 (estimated)

## Conditions studied

- Colorectal Cancer
- Peritoneal (Metastatic) Cancer
- FAPI PET

## Interventions

- **COMBINATION_PRODUCT:** Radiotherapy followed by immunotherapy and chemotherapy
- **DRUG:** Chemotherapy (control)

## Key facts

- **NCT ID:** NCT07079462
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-01
- **Primary completion:** 2026-03-01
- **Final completion:** 2028-05-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07079462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07079462, "Comparing 68Ga-FAPI PET-Guided Abdominal Radiotherapy Combined With Second-Line Standard Therapy and Cadonilimab Versus Second-Line Standard Therapy in Colorectal Cancer With Peritoneal Metastasis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07079462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*